Skip to main content

Table 1 Baseline demographics of patients

From: Characteristics and longitudinal progression of chronic obstructive pulmonary disease in GOLD B patients

Demographic n = 370
Gender (% Male) 65
Age (years) 70.2 (8.8)
Smoking status (Current %) 30.0
Pack years 46.0 [10.0–220.0]
BMI (kg/m2) 26.2 [15.6–49.2]
Exacerbations (1 year prior) 1.0 [0.0–15.0]
Inhaled steroid use % 78.8
Oral steroid use % 3.8
LABA use % 70.7
LAMA use % 75.0
Azithromycin use % 3.5
Post BD FEV1 (L) 1.4 (0.6)
Post BD FEV1 % 57.0 [20.0–117.0]
Post BD Ratio 0.5 [0.2–0.8]
GOLD A n (%) 34 (9.2)
GOLD B n (%) 107 (28.9)
GOLD C n (%) 12 (3.2)
GOLD D n (%) 217 (58.7)
  1. Summaries are presented as percentages, Mean (SD) or Median [Range] as appropriate
  2. Definitions of abbreviations; BMI body mass index, LABA long acting beta agonist, LAMA long acting muscarinic antagonist, Post BD post bronchodilator, FEV 1 forced expired volume in first second